SRPT

Sarepta Therapeutics, Inc. News Headlines

$12
*  
0.30
2.44%
Get SRPT Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading SRPT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Sarepta Therapeutics, Inc. (SRPT): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/27/2015 7:00:00 AM - Investopedia


Convert Catalysts Into Profits: Sagient Research's Edward Stopke
1/23/2015 8:51:00 AM - Seeking Alpha


8 Biotech Stock Controversies Emerging From 'JPM15' Conference
1/20/2015 10:18:00 AM - TheStreet


Seeking Alpha's Biotech Weekly: Roche Takes Control, Shire's A Buyer, And More
1/16/2015 4:00:00 PM - Seeking Alpha


Sarepta Starts Dosing in Duchenne Muscular Dystrophy Study - Analyst Blog
1/15/2015 4:30:00 PM - Zacks.com


Sarepta Therapeutics Will Present At J.P. Morgan Conference; Webcast At 3:00 PM
1/15/2015 2:00:00 PM - RTT News


Sarepta Is Suffering From Overreaction
1/15/2015 9:00:00 AM - Seeking Alpha


Sarepta Starts Dosing in Duchenne Muscular Dystrophy Study - Analyst Blog
1/15/2015 4:30:00 AM - Investopedia


Sarepta Therapeutics Slumps: SRPT Falls 14.6% in Session - Tale of the Tape
1/13/2015 9:00:00 AM - Zacks.com


BioMarin Shows Up Rival Sarepta During 'JPM15' Investor Presentation
1/12/2015 2:38:00 PM - TheStreet


Why Sarepta Theraputics Inc's Shares Crashed
1/12/2015 2:23:42 PM - Motley Fool


Sarepta Therapeutics (SRPT) Stock Hits One-Year Low Today After Eteplirsen Update
1/12/2015 12:51:00 PM - TheStreet


Why Sarepta Therapeutics Inc. Stock Tumbled 15% in December
1/9/2015 7:04:01 AM - Motley Fool


PTC Therapeutics Starts Rolling NDA Filing for Translarna - Analyst Blog
12/24/2014 4:10:00 PM - Zacks.com


PTC Therapeutics Starts Rolling NDA Filing for Translarna - Analyst Blog
12/24/2014 4:10:00 AM - Investopedia


Why Is George Soros Buying This Beaten Down Biotech Stock?
12/21/2014 11:04:03 AM - Motley Fool


Doug Loe: Canada Has Earned Its Spot In The Biotech All-Star Team Photo
12/19/2014 10:53:00 AM - Seeking Alpha


Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog
12/18/2014 7:07:00 PM - Zacks.com


Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog
12/18/2014 7:07:00 AM - Investopedia


BIOD To Report Data Next Month, HALO Shines On Deal News, TTPH Gets Ignited
12/17/2014 11:26:00 PM - RTT News


Does George Soros Think Biotech's Bull Run Is Finally Coming to an End?
12/15/2014 7:45:02 AM - Motley Fool


With Mid-2015 NDA Submission, Sarepta Can Rise
12/12/2014 9:35:00 AM - Seeking Alpha


Sarepta Therapeutics To Present At Oppenheimer Conference; Webcast At 11:30 AM
12/10/2014 10:30:00 AM - RTT News


The 3 Most Memorable Moments in Healthcare This Year
12/7/2014 3:02:02 PM - Motley Fool


Health Care Sector Update for 11/26/2014: SRPT,RNA,BMRN,BDX,MRGE
11/26/2014 4:00:03 PM - MT Newswires